P95 is a global leader in epidemiology, vaccines, and infectious disease research, founded in 2011 and headquartered in Belgium. The company collaborates with public health agencies, pharmaceutical companies, academic institutions, and global organizations such as WHO and the European Commission to generate actionable insights that improve access to safe and effective vaccines. Recently, P95 joined forces with Julius Clinical, a leading clinical CRO, to enhance their integrated portfolio of epidemiological and clinical research services. With a diverse team of nearly 500 professionals from around 40 nationalities, P95 operates across multiple continents, fostering a collaborative and inclusive culture that emphasizes scientific rigor, innovation, and a commitment to improving global health outcomes.